These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24072835)

  • 61. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.
    Delle Karth G; Geppert A; Neunteufl T; Priglinger U; Haumer M; Gschwandtner M; Siostrzonek P; Heinz G
    Crit Care Med; 2001 Jun; 29(6):1149-53. PubMed ID: 11395591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Amiodarone-induced thyrotoxicosis: a diagnostic and therapeutic challenge].
    Schuetz P; Eriksson U; Christ-Crain M; Zulewski H; Miller B
    Praxis (Bern 1994); 2005 Sep; 94(36):1397-401. PubMed ID: 16190373
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prescribing amiodarone: an evidence-based review of clinical indications.
    Vassallo P; Trohman RG
    JAMA; 2007 Sep; 298(11):1312-22. PubMed ID: 17878423
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Current role of amiodarone in antiarrhythmic therapy].
    Sohns C; Zabel M
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):239-43. PubMed ID: 21104260
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis.
    Uzan L; Guignat L; Meune C; Mouly S; Weber S; Bertagna X; Bertherat J; Thomopoulos P; Duboc D
    Drug Saf; 2006; 29(3):231-6. PubMed ID: 16524322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of chronic amiodarone therapy on excitable gap during typical human atrial flutter.
    Maury P; Zimmermann M
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1416-23. PubMed ID: 15610289
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction.
    Kum LC; Chan WW; Hui HH; Wong GW; Ho SS; Sanderson JE; Yu CM; Fung JW
    Clin Cardiol; 2006 Jul; 29(7):295-9. PubMed ID: 16881537
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Amiodarone-induced hypothyroidism and other adverse effects.
    Mosher MC
    Dimens Crit Care Nurs; 2011; 30(2):87-93. PubMed ID: 21307683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ECMO for cardiac rescue in a neonate with accidental amiodarone overdose.
    Haas NA; Wegendt C; Schäffler R; Kirchner G; Welisch E; Kind K; Blanz U; Kececioglu D
    Clin Res Cardiol; 2008 Dec; 97(12):878-81. PubMed ID: 18712427
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery.
    Mitchell LB;
    Can J Cardiol; 2011; 27(1):91-7. PubMed ID: 21329866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute hepatitis complicating intravenous amiodarone treatment.
    Agozzino F; Picca M; Pelosi G
    Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Lewalter T
    J Am Coll Cardiol; 2010 Mar; 55(10):1051-2; author reply 1052-3. PubMed ID: 20202525
    [No Abstract]   [Full Text] [Related]  

  • 75. Amiodarone for rapid cardioversion of chronic atrial tachyarrhythmia?
    Nielsen KD; Møller S
    Pharmacol Toxicol; 2000 Jun; 86(6):283-6. PubMed ID: 10895992
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Repeated electrical cardioversions and amiodarone for recurrent neonatal atrial flutter].
    Crochelet AS; Jacquemart C; Massin M
    Arch Pediatr; 2015 Oct; 22(10):1032-4. PubMed ID: 26216065
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.
    Larbuisson R; Venneman I; Stiels B
    J Cardiothorac Vasc Anesth; 1996 Feb; 10(2):229-34. PubMed ID: 8850403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Spontaneous remission of an amiodarone-induced pulmonary lesion].
    Müller M; Schima W; Weissel M
    Wien Klin Wochenschr; 1997 Nov; 109(22):887-9. PubMed ID: 9476338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.